Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

Keith C. Bible(Mayo Clinic in Arizona), Vera J. Suman(Mayo Clinic), Julian R. Molina(Mayo Clinic in Arizona), Robert C. Smallridge(WinnMed), William J. Maples(Mayo Clinic in Florida), Michael E. Menefee(Mayo Clinic in Florida), Joseph Rubin(Mayo Clinic in Arizona), Kostandinos Sideras(Mayo Clinic in Arizona), John C. Morris(Mayo Clinic in Arizona), Bryan McIver(Mayo Clinic in Arizona), Jill K. Burton(Mayo Clinic in Arizona), Kevin Webster(Mayo Clinic in Arizona), Carolyn Bieber(Mayo Clinic in Florida), Anne M. Traynor(University of Wisconsin Carbone Cancer Center), Patrick J. Flynn(Minnesota Oncology), Boon Cher Goh(National University Hospital), Hui Tang(Mayo Clinic), Susan Percy Ivy(National Cancer Institute), Charles Erlichman(Mayo Clinic in Arizona)
The Lancet Oncology
September 21, 2010
10.1016/s1470-2045(10)70203-5
Cited by 415Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis